As previously reported, Erste Group reinstated coverage of CME Group (CME) with a Buy rating on Friday. CME’s products are “the world’s most comprehensive risk management tools for traders ...

2-Year U.S. Treasury Note Continuous Contract $103.371-0.008-0.01% 5-Year U.S. Treasury Note Continuous Contract $107.609-0.016-0.01% 10-Year U.S. Treasury Note Continuous Contract $110.516-0.031 ...

CME Group (CME) is doubling down on crypto derivatives. The world’s largest derivatives marketplace announced it will launch Solana (SOL-USD) futures on March 17, pending regulatory approval ...

CHICAGO, March 18, 2025 /PRNewswire/ -- CME Group, the world's leading derivatives marketplace, today announced its new Solana (SOL) futures are now available for trading in both a micro-sized (25 ...

2-Year U.S. Treasury Note Continuous Contract $103.414-0.070-0.07% 5-Year U.S. Treasury Note Continuous Contract $107.773-0.164-0.15% 10-Year U.S. Treasury Note Continuous Contract $110.906-0.188 ...

Chipps Facial Plastics & Dermatology is pleased to announce that Lisa Chipps, MD, MS, distinguished board-certified ...

Goyer amid production restarts and budget adjustments, things are looking up for Apple TV+‘s sci-fi drama Foundation. With the completed third season not yet scheduled but likely to debut this ...

And if the Fed does cut rates this year, the first cut may not come until June or July, according to the CME FedWatch tool ... Resident with the Harpswell Foundation in Phnom Penh, Cambodia ...

ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, announces its ...

KT&G Scholarship Foundation, in cooperation with Almaty Management University ... at 18:46 FalconX Executes First-Ever CME Group SOL Futures Trade with StoneX FalconX, a leading digital asset prime ...

Sean Feucht, who has called his opponents "literally Satan," gushed about the opportunity to give Trump's Cabinet "advice" on how to rebuild Los Angeles. By Ja'han Jones A Christian extremist ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.